Scinai Immunotherapeutics (SCNI) has released an update.
Scinai Immunotherapeutics is set to hold its Annual General Meeting on November 21, 2024, to discuss key proposals including board re-elections and amendments to its Articles of Association. Shareholders will vote on increasing authorized shares and updating executive compensation policies to align with NASDAQ standards. The meeting will also ratify the appointment of auditors and provide shareholders an opportunity to review the company’s financial statements.
For further insights into SCNI stock, check out TipRanks’ Stock Analysis page.
